First-line treatment of chronic lymphocytic leukemia with ibrutinib plus obinutuzumab versus chlorambucil plus obinutuzumab: final analysis of the randomized, phase III iLLUMINATE... by Moreno, Carol, Greil, Richard, Demirkan, Fatih, Tedeschi, Alessandra, Anz, Bertrand, Larratt, Loree, Simkovic, Martin, Novak, Jan, Strugov, Vladimir, Gill, Devinder, Gribben, John G, Kwei, Kevin, Dai, Sandra, Hsu, Emily, Dean, James P, Flinn, Ian W

Get full text

Ibrutinib plus obinutuzumab versus chlorambucil plus obinutuzumab in first-line treatment of chronic lymphocytic leukaemia (iLLUMINATE): a multicentre, randomised, open-label, phas... by Moreno, Carol, Greil, Richard, Demirkan, Fatih, Tedeschi, Alessandra, Anz, Bertrand, Larratt, Loree, Simkovic, Martin, Samoilova, Olga, Novak, Jan, Ben-Yehuda, Dina, Strugov, Vladimir, Gill, Devinder, Gribben, John G, Hsu, Emily, Lih, Chih-Jian, Zhou, Cathy, Clow, Fong, James, Danelle F, Styles, Lori, Flinn, Ian W

Get full text

COVID-19 severity and mortality in patients with chronic lymphocytic leukemia: a joint study by ERIC, the European Research Initiative on CLL, and CLL Campus by Scarfò, Lydia, Chatzikonstantinou, Thomas, Rigolin, Gian Matteo, Quaresmini, Giulia, Motta, Marina, Vitale, Candida, Garcia-Marco, Jose Antonio, Hernández-Rivas, José Ángel, Mirás, Fatima, Baile, Mónica, Marquet, Juan, Niemann, Carsten U., Reda, Gianluigi, Munir, Talha, Gimeno, Eva, Marchetti, Monia, Quaglia, Francesca Maria, Varettoni, Marzia, Delgado, Julio, Iyengar, Sunil, Janssens, Ann, Marasca, Roberto, Ferrari, Angela, Cuéllar-García, Carolina, Itchaki, Gilad, Špaček, Martin, De Paoli, Lorenzo, Laurenti, Luca, Levin, Mark-David, Lista, Enrico, Mauro, Francesca R., Šimkovič, Martin, Van Der Spek, Ellen, Vandenberghe, Elisabeth, Trentin, Livio, Wasik-Szczepanek, Ewa, Ruchlemer, Rosa, Bron, Dominique, De Paolis, Maria Rosaria, Del Poeta, Giovanni, Farina, Lucia, Foglietta, Myriam, Gentile, Massimo, Herishanu, Yair, Herold, Tobias, Jaksic, Ozren, Kater, Arnon P., Kersting, Sabina, Malerba, Lara, Orsucci, Lorella, Popov, Viola Maria, Sportoletti, Paolo, Yassin, Mohamed, Pocali, Barbara, Barna, Gabor, Chiarenza, Annalisa, dos Santos, Gimena, Nikitin, Eugene, Andres, Martin, Dimou, Maria, Doubek, Michael, Enrico, Alicia, Hakobyan, Yervand, Kalashnikova, Olga, Ortiz Pareja, Macarena, Papaioannou, Maria, Rossi, Davide, Shah, Nimish, Shrestha, Amit, Stanca, Oana, Stavroyianni, Niki, Strugov, Vladimir, Tam, Constantine, Zdrenghea, Mihnea, Coscia, Marta, Stamatopoulos, Kostas, Rossi, Giuseppe, Rambaldi, Alessandro, Montserrat, Emili’, Foà, Robin, Cuneo, Antonio, Ghia, Paolo

Get full text

Impact of age and comorbidities on the efficacy of FC and FCR regimens in chronic lymphocytic leukemia by Strugov, Vladimir, Stadnik, Elena, Virts, Yulia, Andreeva, Tatyana, Zaritskey, Andrey

Get full text

Five‐year survival follow‐up of a phase III randomised trial comparing ofatumumab versus physicians' choice for bulky fludarabine‐refractory chronic lymphocytic leukaemia: a short... by Miklos, Udvardy, Strugov, Vladimir, Lewerin, Catharina, Grosicki, Sebastian, Mazur, Grzegorz, Steurer, Michael, Montillo, Marco, Kryachok, Irina, Middeke, Jan M., Rekhtman, Grygoriy, Stefanelli, Tommaso, Vincent, Ghislaine, Govindaraju, Sameera, Österborg, Anders

Get full text

Five-Year Follow-up of Safety and Efficacy of a Phase III Randomized Trial of Ofatumumab Therapy Versus Physicians' Choice in Patients with Bulky Fludarabine Refractory Chronic Lym... by Miklos, Udvardy, Strugov, Vladimir, Lewerin, Catharina, Grosicki, Sebastian, Mazur, Grzegorz, Steurer, Michael, Montillo, Marco, Kryachok, Irina, Middeke, Jan Moritz, Rekhtman, Grygoriy, Stefanelli, Tommaso, Vincent, Ghislaine, G, Sameera, Österborg, Anders

Get full text

Impact of MRD Eradication on Survival Outcomes in CLL Patients with Different IGHV Mutation Status by Timofeeva, Natalia, Mirolyubova, Iuliya, Stadnik, Elena, Andreeva, Tatyana, Strugov, Vladimir, Rumyantsev, Andrey, Zaritskey, Andrey

Get full text

BTK and PLCG2 remain unmutated in one-third of patients with CLL relapsing on ibrutinib by Bonfiglio, Silvia, Sutton, Lesley-Ann, Ljungström, Viktor, Capasso, Antonella, Pandzic, Tatjana, Weström, Simone, Foroughi-Asl, Hassan, Skaftason, Aron, Gellerbring, Anna, Lyander, Anna, Gandini, Francesca, Gaidano, Gianluca, Trentin, Livio, Bonello, Lisa, Reda, Gianluigi, Bödör, Csaba, Stavroyianni, Niki, Tam, Constantine S., Marasca, Roberto, Forconi, Francesco, Panayiotidis, Panayiotis, Ringshausen, Ingo, Jaksic, Ozren, Frustaci, Anna Maria, Iyengar, Sunil, Coscia, Marta, Mulligan, Stephen P., Ysebaert, Loïc, Strugov, Vladimir, Pavlovsky, Carolina, Walewska, Renata, Österborg, Anders, Cortese, Diego, Ranghetti, Pamela, Baliakas, Panagiotis, Stamatopoulos, Kostas, Scarfò, Lydia, Rosenquist, Richard, Ghia, Paolo

Get full text

Efficacy of Ibrutinib in the Treatment of First Early Relapses of CLL by Timofeeva, Natalia, Strugov, Vladimir, Stadnik, Elena, Mirolyubova, Yuliya, Nikulina, Tatyana, Lomaia, Elza

Get full text

Ibrutinib + Obinutuzumab Versus Chlorambucil + Obinutuzumab As First-Line Treatment in Patients with Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma (CLL/SLL): Results f... by Moreno, Carol, Greil, Richard, Demirkan, Fatih, Tedeschi, Alessandra, Anz, Bertrand, Larratt, Loree, Simkovic, Martin, Samoilova, Olga, Novak, Jan, Ben-Yehuda, Dina, Strugov, Vladimir, Gill, Devinder, Gribben, John G., Hsu, Emily, Zhou, Cathy, Clow, Fong, James, Danelle F., Styles, Lori, Flinn, Ian W.

Get full text

9 Year Follow-up After Initial Treatment with FC and FCR Regimens In Chronoc Lymphocytic Leukemia - Impact of pretreatment CIRS by Stadnik, Elena, Strugov, Vladimir, Virts, Yulia, Zaritskey, Andrey

Get full text

Prospective Evaluation of Safety and Efficacy of BR Regimen in Previously Untreated CLL Patients by Stadnik, Elena, Strugov, Vladimir, Andreeva, Tatyana, Virts, Yulia, Ilyina, Natalya, Mirolubova, Yulia, Butylin, Pavel, Zaritskey, Andrey

Get full text

Efficacy Of Different Therapeutic Approaches In Blastic Phase Of Chronic Myeloid Leukemia: Single Centre Experience by Lomaia, Elza, Romanova, Ekaterina, Girshova, Larisa, Alexeeva, Yulia, Sbityakova, Eugenia, Goriunova, Elena, Strugov, Vladimir, Lazorko, Natalia, Siordia, Nadia, Mescheryakova, Diana, Silina, Tatiana, Motorin, Dmitry, Zaritskey, Andrey

Get full text

First Line BR in Chronic Lymphocytic Leukemia Patients: Interim Results of Russian Norma Trial by Stadnik, Elena, Strugov, Vladimir, Silina, Tatyana, Ilyina, Natalya, Virts, Yulia, Badaev, Renat, Kuchma, Galina, Volodicheva, Elena, Sycheva, Tatyana, Kaporskaya, Tatyana, Kaplanov, Kamil, Glonina, Natalya, Anchukova, Lyubov, Byalik, Tatyana, Samoilova, Olga, Kirillova, Elena, Shklyaev, Sergey, Mirolubova, Yulia, Nikulina, Tatyana, Rumyantsev, Andrey, Proydakov, Andrey, Lysenko, Irina, Melnichenko, Vladimir, Esefeva, Natalya, Ksenzova, Tatyana, Davidkin, Igor, Vasilyeva, Olga, Ochirova, Oksana, Rukavitsyn, Oleg, Bulieva, Natalya, Zherebtsova, Vera, Gubkin, Andrey, Bogdanova, Yulia, Chebykina, Irina, Shukaeva, Elena, Zaritskey, Andrey

Get full text

Assessment of radiation-protective properties of Y2O3-MnO2-Al2O3-SiO2-CaO using Phy-X software and Geant4 simulation code by Aladailah, M. W., Shirmanov, I. A., Strugov, E. D., Tashlykov, O. L., Eke, C., Yildirim, A.

Get full text

Assessment of protective properties of glasses with the application of golmium oxide against Gamma radiation by Shirmanov, I. A., Strugov, E. D., Aladailah, M. W., Tashlykov, O. L., Abualsayed, M. I., Askin, A.

Get full text